Plasma biomarkers such as p‐tau217, p‐tau181, the Aβ1‐42/Aβ1‐40 ratio, and neurofilament light chain (NfL) have shown specificity for AD.7, 8, 9, 10, 11, 12. This evidence concerns the gene NEFL and Alzheimer disease.